The hydrogen sulfide donor 4-carboxyphenyl-isothiocyanate decreases blood pressure and promotes cardioprotective effect through reduction of oxidative stress and nuclear factor kappa B/matrix metalloproteinase (MMP)-2 axis in hypertension

Life Sci. 2024 Aug 15:351:122819. doi: 10.1016/j.lfs.2024.122819. Epub 2024 Jun 8.

Abstract

Aims: Our aim was to evaluate whether the hydrogen sulfide (H2S) donor, 4-carboxyphenyl-isothiocyanate (4-CPI), exerts cardioprotective effect in the two kidney- one clip (2K-1C) rats through oxidative stress and MMP-2 activity attenuation and compare it with the classical H2S donor, Sodium Hydrosulfide (NaHS).

Materials and methods: Renovascular hypertension (two kidneys-one clip; 2K-1C) was surgically induced in male Wistar rats. After two weeks, normotensive (2K) and hypertensive rats were intraperitoneally treated with vehicle (0.6 % dimethyl sulfoxide), NaHS (0.24 mg/Kg/day) or with 4-CPI (0.24 mg/Kg/day), for more 4 weeks. Systolic blood pressure (SBP) was evaluated weekly by tail-cuff plethysmography. Heart function was assessed by using the Millar catheter. Cardiac hypertrophy and fibrosis were evaluated by hematoxylin and eosin, and Picrosirius Red staining, respectively. The H2S was analyzed using WSP-1 fluorimetry and the cardiac oxidative stress was measured by lucigenin chemiluminescence and Amplex Red. MMP-2 activity was measured by in-gel gelatin or in situ zymography assays. Nox1, gp91phox, MMP-2 and the phospho-p65 subunit (Serine 279) nuclear factor kappa B (NF-κB) levels were evaluated by Western blotting.

Key findings: 4-CPI reduced blood pressure in hypertensive rats, decreased cardiac remodeling and promoted cardioprotection through the enhancement of cardiac H2S levels. An attenuation of oxidative stress, with inactivation of the p65-NF-κB/MMP-2 axis was similarly observed after NaHS or 4-CPI treatment in 2K-1C hypertension.

Significance: H2S is a mediator that promotes cardioprotective effects and decreases blood pressure, and 4-CPI seems to be a good candidate to reverse the maladaptive remodeling and cardiac dysfunction in renovascular hypertension.

Keywords: Cardiac dysfunction; Cardiac hypertrophic remodeling; Hydrogen sulfide (H(2)S) donors; Hypertension; Matrix metalloproteinase 2 (MMP-2).

MeSH terms

  • Animals
  • Blood Pressure* / drug effects
  • Cardiotonic Agents / pharmacology
  • Hydrogen Sulfide* / metabolism
  • Hydrogen Sulfide* / pharmacology
  • Hypertension / drug therapy
  • Hypertension / metabolism
  • Hypertension, Renovascular / drug therapy
  • Hypertension, Renovascular / metabolism
  • Hypertension, Renovascular / physiopathology
  • Isothiocyanates / pharmacology
  • Male
  • Matrix Metalloproteinase 2* / metabolism
  • NF-kappa B* / metabolism
  • Oxidative Stress* / drug effects
  • Rats
  • Rats, Wistar
  • Sulfides / pharmacology

Substances

  • Cardiotonic Agents
  • Hydrogen Sulfide
  • Isothiocyanates
  • Matrix Metalloproteinase 2
  • Mmp2 protein, rat
  • NF-kappa B
  • Sulfides